Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Levitzki

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|July 19, 2003
Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimicsGalia Blum, Aviv Gazit, Alexander Levitzki
Nature Reviews. Cancer|June 21, 2005
Killing time for cancer cellsShoshana Klein, Frank McCormick, Alexander Levitzki
Seminars in Cancer Biology|October 18, 2003
Tumor specific activation of PKR as a non-toxic modality of cancer treatmentAlexei Shir, Inbar Friedrich, Alexander Levitzki
Current Opinion in Pharmacology|May 8, 2013
Targeted cancer immunotherapyMaya Zigler, Alexei Shir, Alexander Levitzki
Cellular Signalling|September 15, 2014
Transmembrane signaling in Saccharomyces cerevisiae as a model for signaling in metazoans: state of the art after 25 yearsDavid Engelberg, Riki Perlman, Alexander Levitzki
Cancer Biology & Therapy|August 27, 2005
Activation of dsRNA dependent protein kinase PKR in Karpas299 does not lead to cell deathInbar Friedrich, Hannah Ben-Bassat, Alexander Levitzki
Bioorganic & Medicinal Chemistry|August 3, 2010
Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitorsIdit Sagiv-Barfi, Ester Weiss, Alexander Levitzki
Seminars in Cancer Biology|June 29, 2004
RNA molecules as anti-cancer agentsInbar Friedrich, Alexei Shir, Shoshana Klein, et al.
Plos Medicine|December 2, 2005
EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in miceAlexei Shir, Manfred Ogris, Ernst Wagner, et al.
The Journal of Biological Chemistry|July 18, 2003
Tyrphostin AG 555 inhibits bovine papillomavirus transcription by changing the ratio between E2 transactivator/repressor functionSabine Baars, Anastasia Bachmann, Alexander Levitzki, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|July 19, 2003
Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimicsGalia Blum, Aviv Gazit, Alexander Levitzki
Nature Reviews. Cancer|June 21, 2005
Killing time for cancer cellsShoshana Klein, Frank McCormick, Alexander Levitzki
Seminars in Cancer Biology|October 18, 2003
Tumor specific activation of PKR as a non-toxic modality of cancer treatmentAlexei Shir, Inbar Friedrich, Alexander Levitzki
Current Opinion in Pharmacology|May 8, 2013
Targeted cancer immunotherapyMaya Zigler, Alexei Shir, Alexander Levitzki
Cellular Signalling|September 15, 2014
Transmembrane signaling in Saccharomyces cerevisiae as a model for signaling in metazoans: state of the art after 25 yearsDavid Engelberg, Riki Perlman, Alexander Levitzki
Cancer Biology & Therapy|August 27, 2005
Activation of dsRNA dependent protein kinase PKR in Karpas299 does not lead to cell deathInbar Friedrich, Hannah Ben-Bassat, Alexander Levitzki
Bioorganic & Medicinal Chemistry|August 3, 2010
Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitorsIdit Sagiv-Barfi, Ester Weiss, Alexander Levitzki
Seminars in Cancer Biology|June 29, 2004
RNA molecules as anti-cancer agentsInbar Friedrich, Alexei Shir, Shoshana Klein, et al.
Plos Medicine|December 2, 2005
EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in miceAlexei Shir, Manfred Ogris, Ernst Wagner, et al.
The Journal of Biological Chemistry|July 18, 2003
Tyrphostin AG 555 inhibits bovine papillomavirus transcription by changing the ratio between E2 transactivator/repressor functionSabine Baars, Anastasia Bachmann, Alexander Levitzki, et al.
Pageof 10